The article is bit of a link bait. It's not about drinking blood but obtaining some of the blood factors via medical process.
After being given plasma — the main component of blood — from volunteers ages 16 to 25, researchers noted improvements in biomarkers for various diseases.
The study was done in mice funded by Peter Thiel. However people doing study have commercial interest. They are in business of selling teenage blood plasma to customers at a cost of $8,000 for 2½ liters.
I find it extremely unsettling to see this type of headline over and over again in tech/science journalism and HN. Someone has come up with a new way to make a buck and are on the process of making it widely know. The silicon valley hype cycles has started. The problem is that there is no strong independent evidence.
When you're dealing with people's health Money making needs to take a backseat to strong well-defined science. Move fast and break things is not the mantra we need to follow here.
The article is bit of a link bait. It's not about drinking blood but obtaining some of the blood factors via medical process.
After being given plasma — the main component of blood — from volunteers ages 16 to 25, researchers noted improvements in biomarkers for various diseases.
The study was done in mice funded by Peter Thiel. However people doing study have commercial interest. They are in business of selling teenage blood plasma to customers at a cost of $8,000 for 2½ liters.
Original Nature article link here: https://www.nature.com/articles/s41586-018-0457-8
Silicon Valley episode was very much inspired from this :).